Paragon's hub-and-spoke biotech model yields another reverse merger
BioPharma
Bridgebio Pharma Samarth Kulkarni Aeglea Biotherapeutics Peter Harwin Lawrence Klein Carl Dambkowski
Source: biopharmadive.com
📰 Cameron Turtle News
Cameron Turtle News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cameron Turtle. Real-time updates on events, politics, business and more.
Rx Rundown: The FDA, Amgen, Spyre Therapeutics and more
Check out this week’s medical marketing news, people on the move and industry chatter.
Source: mmm-online.com
Aeglea rebrands to Spyre Therapeutics, names new CEO amid leadership changes
The biotech focused on novel antibody therapies will now be called Spyre Therapeutics, as part of a rebrand to expand its inflammatory bowel disease pipeline.
Source: mmm-online.com
Aeglea BioTherapeutics Changes Name To Spyre Therapeutics; To Begin Trading Under Symbol SYRE
(RTTNews) - Aeglea BioTherapeutics, Inc. (AGLE) announced its name change to Spyre Therapeutics, Inc. Effective as of market open on November 28, ...
Jeffrey Albers Laurie Stelzer Eidos Therapeutics Inc Aeglea Biotherapeutics Inc Spyre Therapeutics Inc Strategy Bio Pharma Inc
Source: businessinsider.com
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones
/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (Nasdaq: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the...
United States Provention Bio Aeglea Biotherapeutics Heidy Abreu King Jones Scott Burrows Jonathan Alspaugh
Source: prnewswire.com
Aeglea BioTherapeutics Reports Second Quarter 2023 Financial Results
/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea" or the "Company") (NASDAQ:AGLE), a biotechnology company advancing a pipeline of antibody therapeutics...
United States Aeglea Biotherapeutics Jonathan Alspaugh European Medicines Agency Company Quarterly Report On Form Exchange Commission
Source: prnewswire.com
Aeglea BioTherapeutics Announces Grant of Inducement Awards
/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ: AGLE) today announced that, in connection with the acquisition of Spyre Therapeutics, Inc....
United States Aeglea Biotherapeutics Aeglea Biotheraeutics Spyre Aeglea Biotherapeutics Inc Prnewswire Aeglea Biotherapeutics Inc Spyre Therapeutics Inc
Source: prnewswire.com
Aeglea BioTherapeutics Announces Grant of Inducement Awards
AUSTIN, Texas and WALTHAM, Mass., June 23, 2023 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (
United States Aeglea Biotherapeutics Aeglea Biotheraeutics Spyre Prnewswire Aeglea Biotherapeutics Inc Aeglea Biotherapeutics Inc Spyre Therapeutics Inc
Source: marketscreener.com
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics
Acquisition of Spyre and concurrent oversubscribed $210 million private investment positions the company to advance a leading inflammatory bowel disease (IBD)...
Source: prnewswire.com
Nektar Therapeutics to Host Investor & Analyst Event on December 12th
SAN FRANCISCO, Dec. 5, 2022 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that it will host an investor and analyst event on ...
Source: businessinsider.com